Abstract
The aim of this study was to evaluate the immunoregulatory effects of recombinant human lactoferrin (rhLF) in two in vitro models: (1) the secondary humoral immune response to sheep erythrocytes (SRBC); and (2) the mixed lymphocyte reaction (MLR). We compared the non-sialylated glycoform of rhLF as expressed by glycoengineered Pichia pastoris with one that was further chemically sialylated. In an earlier study, we showed that sialylated rhLF could reverse methotrexate-induced suppression of the secondary immune response of mouse splenocytes to SRBC, and that the phenomenon is dependent on the interaction of lactoferrin (LF) with sialoadhesin (CD169). We found that the immunorestorative activity of sialylated rhLF is also dependent on its interaction with the CD22 antigen, a member of the immunoglobulin superfamily that is expressed by B lymphocytes. We also demonstrated that only sialylated rhLF was able to inhibit the MLR reaction. MLR was inhibited by bovine lactoferrin (bLF), a glycoform that has a more complex glycan structure. Desialylated bLF and lactoferricin, a bLF-derived peptide devoid of carbohydrates, did not express such inhibitory activity. We showed that the interaction of LF with sialic acid receptors is essential for at least some of the immunoregulatory activity of this glycoprotein.
[1] Legrand, D., Pierce, A., Elass, E., Carpentier, M., Mariller, C. and Mazurier, J. Lactoferrin structure and functions. Adv. Exp. Med. Biol. 606 (2008) 163–194. http://dx.doi.org/10.1007/978-0-387-74087-4_610.1007/978-0-387-74087-4_6Search in Google Scholar
[2] Vogel, H.J. Lactoferrin, a bird’s eye view. Biochem. Cell Biol. 90 (2012) 233–244. http://dx.doi.org/10.1139/o2012-01610.1139/o2012-016Search in Google Scholar
[3] Kruzel, M.L., Actor, J.K., Boldogh, I. and Zimecki, M. Lactoferrin in health and disease. Postepy Hig. Med. Dosw. 61 (2007) 261–267. Search in Google Scholar
[4] Kruzel, M.L., Actor, J.K., Radak, Z., Bacsi, A., Saavedra-Molina, A. and Boldogh, I. Lactoferrin decreases LPS-induced mitochondrial dysfunction in cultured cells and in animal endotoxemia model. Innate Immun. 16 (2010) 67–79. http://dx.doi.org/10.1177/175342590910531710.1177/1753425909105317Search in Google Scholar
[5] Jonasch, E., Stadler, W.M., Bukowski, R.M., Hayes, T.G., Varadhachary, A., Malik, R., Figlin, R.A. and Srinivas, S. Phase 2 trial of talactoferrin in previously treated patients with metastatic renal cell carcinoma. Cancer 113 (2008) 72–77. http://dx.doi.org/10.1002/cncr.2351910.1002/cncr.23519Search in Google Scholar
[6] Baldi, A., Ioannis, P., Chiara, P., Eleonora, F., Roubini, C. and Vittorio, D. Biological effects of milk proteins and their peptides with emphasis on those related to the gastrointestinal ecosystem. J. Dairy Res. 72 (2005) 66–72. http://dx.doi.org/10.1017/S002202990500110X10.1017/S002202990500110XSearch in Google Scholar
[7] Weinberg, E.D. Iron, infection, and neoplasia. Clin. Physiol. Biochem. 4 (1986) 50–60. Search in Google Scholar
[8] Hendrixson, D.R., Qiu, J., Shewry, S.C., Fink, D.L., Petty, S., Baker, E.N., Plaut, A.G. and St Geme, J.W., 3rd. Human milk lactoferrin is a serine protease that cleaves Haemophilus surface proteins at arginine-rich sites. Mol. Microbiol. 47 (2003) 607–617. http://dx.doi.org/10.1046/j.1365-2958.2003.03327.x10.1046/j.1365-2958.2003.03327.xSearch in Google Scholar
[9] Appelmelk, B.J., An, Y.Q., Geerts, M., Thijs, B.G., de Boer, H.A., MacLaren, D.M., de Graaff, J. and Nuijens, J.H. Lactoferrin is a lipid A-binding protein. Infect. Immun. 62 (1994) 2628–2632. Search in Google Scholar
[10] Zimecki, M., Mazurier, J., Machnicki, M., Wieczorek, Z., Montreuil, J. and Spik, G. Immunostimulatory activity of lactotransferrin and maturation of CD4-CD8-murine thymocytes. Immunol. Lett. 30 (1991) 119–123. http://dx.doi.org/10.1016/0165-2478(91)90099-V10.1016/0165-2478(91)90099-VSearch in Google Scholar
[11] Zimecki, M., Mazurier, J., Spik, G. and Kapp, J.A. Human lactoferrin induces phenotypic and functional changes in murine splenic B cells. Immunology 86 (1995) 122–127. Search in Google Scholar
[12] Artym, J. and Zimecki, M. The effects of lactoferrin on myelopoiesis: can we resolve the controversy? Postepy Hig. Med. Dosw. 61 (2007) 129–150. Search in Google Scholar
[13] Legrand, D., Elass, E., Carpentier, M. and Mazurier, J. Interactions of lactoferrin with cells involved in immune function. Biochem. Cell Biol. 84 (2006) 282–290. http://dx.doi.org/10.1139/o06-04510.1139/o06-045Search in Google Scholar PubMed
[14] Fischer, R., Debbabi, H., Dubarry, M., Boyaka, P. and Tome, D. Regulation of physiological and pathological Th1 and Th2 responses by lactoferrin. Biochem. Cell Biol. 84 (2006) 303–311. http://dx.doi.org/10.1139/o06-05810.1139/o06-058Search in Google Scholar PubMed
[15] Zimecki, M., Stepniak, D., Szynol, A. and Kruzel, M.L. Lactoferrin regulates proliferative response of human peripheral blood mononuclear cells to phytohemagglutinin and mixed lymphocyte reaction. Arch. Immunol. Ther. Exp. (Warsz.). 49 (2001) 147–154. Search in Google Scholar
[16] Suzuki, Y.A., Lopez, V. and Lonnerdal, B. Mammalian lactoferrin receptors: structure and function. Cell. Mol. Life Sci. 62 (2005) 2560–2575. http://dx.doi.org/10.1007/s00018-005-5371-110.1007/s00018-005-5371-1Search in Google Scholar PubMed
[17] Curran, C.S., Demick, K.P. and Mansfield, J.M. Lactoferrin activates macrophages via TLR4-dependent and -independent signaling pathways. Cell. Immunol. 242 (2006) 23–30. http://dx.doi.org/10.1016/j.cellimm.2006.08.00610.1016/j.cellimm.2006.08.006Search in Google Scholar PubMed
[18] Ando, K., Hasegawa, K., Shindo, K., Furusawa, T., Fujino, T., Kikugawa, K., Nakano, H., Takeuchi, O., Akira, S., Akiyama, T., Gohda, J., Inoue, J. and Hayakawa, M. Human lactoferrin activates NF-kappaB through the Toll-like receptor 4 pathway while it interferes with the lipopolysaccharide-stimulated TLR4 signaling. FEBS J. 277 (2010) 2051–2066. http://dx.doi.org/10.1111/j.1742-4658.2010.07620.x10.1111/j.1742-4658.2010.07620.xSearch in Google Scholar PubMed
[19] Chien, Y.J., Chen, W.J., Hsu, W.L. and Chiou, S.S. Bovine lactoferrin inhibits Japanese encephalitis virus by binding to heparan sulfate and receptor for low density lipoprotein. Virology 379 (2008) 143–151. http://dx.doi.org/10.1016/j.virol.2008.06.01710.1016/j.virol.2008.06.017Search in Google Scholar PubMed
[20] van Berkel, P.H., Geerts, M.E., van Veen, H.A., Mericskay, M., de Boer, H.A. and Nuijens, J.H. N-terminal stretch Arg2, Arg3, Arg4 and Arg5 of human lactoferrin is essential for binding to heparin, bacterial lipopolysaccharide, human lysozyme and DNA. Biochem. J. 328(Pt 1) (1997) 145–151. 10.1042/bj3280145Search in Google Scholar PubMed PubMed Central
[21] Elass-Rochard, E., Legrand, D., Salmon, V., Roseanu, A., Trif, M., Tobias, P.S., Mazurier, J. and Spik, G. Lactoferrin inhibits the endotoxin interaction with CD14 by competition with the lipopolysaccharide-binding protein. Infect. Immun. 66 (1998) 486–491. Search in Google Scholar
[22] Legrand, D., Vigie, K., Said, E.A., Elass, E., Masson, M., Slomianny, M.C., Carpentier, M., Briand, J.P., Mazurier, J. and Hovanessian, A.G. Surface nucleolin participates in both the binding and endocytosis of lactoferrin in target cells. Eur. J. Biochem. 271 (2004) 303–317. http://dx.doi.org/10.1046/j.1432-1033.2003.03929.x10.1046/j.1432-1033.2003.03929.xSearch in Google Scholar PubMed
[23] Shin, K., Wakabayashi, H., Yamauchi, K., Yaeshima, T. and Iwatsuki, K. Recombinant human intelectin binds bovine lactoferrin and its peptides. Biol. Pharm. Bull. 31 (2008) 1605–1608. http://dx.doi.org/10.1248/bpb.31.160510.1248/bpb.31.1605Search in Google Scholar PubMed
[24] Kerrigan, A.M. and Brown, G.D. C-type lectins and phagocytosis. Immunobiology 214 (2009) 562–575. http://dx.doi.org/10.1016/j.imbio.2008.11.00310.1016/j.imbio.2008.11.003Search in Google Scholar PubMed PubMed Central
[25] Paulson, J.C., Macauley, M.S. and Kawasaki, N. Siglecs as sensors of self in innate and adaptive immune responses. Ann. N.Y. Acad. Sci. 1253 (2012) 37–48. http://dx.doi.org/10.1111/j.1749-6632.2011.06362.x10.1111/j.1749-6632.2011.06362.xSearch in Google Scholar PubMed PubMed Central
[26] Kocieba, M., Zimecki, M., Kruzel, M. and Actor, J. The adjuvant activity of lactoferrin in the generation of DTH to ovalbumin can be inhibited by bovine serum albumin bearing alpha-D-mannopyranosyl residues. Cell. Mol. Biol. Lett. 7 (2002) 1131–1136. Search in Google Scholar
[27] Groot, F., Geijtenbeek, T.B., Sanders, R.W., Baldwin, C.E., Sanchez-Hernandez, M., Floris, R., van Kooyk, Y., de Jong, E.C. and Berkhout, B. Lactoferrin prevents dendritic cell-mediated human immunodeficiency virus type 1 transmission by blocking the DC-SIGN-gp120 interaction. J. Virol. 79 (2005) 3009–3015. http://dx.doi.org/10.1128/JVI.79.5.3009-3015.200510.1128/JVI.79.5.3009-3015.2005Search in Google Scholar PubMed PubMed Central
[28] Choi, B.K., Actor, J.K., Rios, S., d’Anjou, M., Stadheim, T.A., Warburton, S., Giaccone, E., Cukan, M., Li, H., Kull, A., Sharkey, N., Gollnick, P., Kocieba, M., Artym, J., Zimecki, M., Kruzel, M.L. and Wildt, S. Recombinant human lactoferrin expressed in glycoengineered Pichia pastoris: effect of terminal N-acetylneuraminic acid on in vitro secondary humoral immune response. Glycoconj. J. 25 (2008) 581–593. http://dx.doi.org/10.1007/s10719-008-9123-y10.1007/s10719-008-9123-ySearch in Google Scholar PubMed PubMed Central
[29] Baveye, S., Elass, E., Fernig, D.G., Blanquart, C., Mazurier, J. and Legrand, D. Human lactoferrin interacts with soluble CD14 and inhibits expression of endothelial adhesion molecules, E-selectin and ICAM-1, induced by the CD14-lipopolysaccharide complex. Infect. Immun. 68 (2000) 6519–6525. http://dx.doi.org/10.1128/IAI.68.12.6519-6525.200010.1128/IAI.68.12.6519-6525.2000Search in Google Scholar
[30] Hwang, S.A., Wilk, K., Kruzel, M.L. and Actor, J.K. A novel recombinant human lactoferrin augments the BCG vaccine and protects alveolar integrity upon infection with Mycobacterium tuberculosis in mice. Vaccine 27 (2009) 3026–3034. http://dx.doi.org/10.1016/j.vaccine.2009.03.03610.1016/j.vaccine.2009.03.036Search in Google Scholar
[31] Artym, J., Zimecki, M. and Kruzel, M.L. Effect of lactoferrin on the methotrexate-induced suppression of the cellular and humoral immune response in mice. Anticancer Res. 24 (2004) 3831–3836. Search in Google Scholar
[32] O’Neill, A.S., van den Berg, T.K. and Mullen, G.E. Sialoadhesin — a macrophage-restricted marker of immunoregulation and inflammation. Immunology 138 (2013) 198–207. http://dx.doi.org/10.1111/imm.1204210.1111/imm.12042Search in Google Scholar
[33] Sunshine, G.H., Katz, D.R. and Czitrom, A.A. Heterogeneity of stimulator cells in the murine mixed leukocyte response. Eur. J. Immunol. 12 (1982) 9–15. http://dx.doi.org/10.1002/eji.183012010510.1002/eji.1830120105Search in Google Scholar
[34] Unanue, E.R. Antigen-presenting function of the macrophage. Annu. Rev. Immunol. 2 (1984) 395–428. http://dx.doi.org/10.1146/annurev.iy.02.040184.00214310.1146/annurev.iy.02.040184.002143Search in Google Scholar
[35] Nitschke, L. CD22 and Siglec-G: B-cell inhibitory receptors with distinct functions. Immunol. Rev. 230 (2009) 128–143. http://dx.doi.org/10.1111/j.1600-065X.2009.00801.x10.1111/j.1600-065X.2009.00801.xSearch in Google Scholar
[36] Lisowska, E., Duk, M. and Wu, A.M. Preparation of biotinylated lectins and application in microtiter plate assays and Western blotting. In: A Laboratory Guide to Biotin-Labeling in Biomolecule Analysis, BioMethods 7 (1996) 115–129. http://dx.doi.org/10.1007/978-3-0348-7349-9_710.1007/978-3-0348-7349-9_7Search in Google Scholar
[37] Endo, Y. and Kobata, A. Partial purification and characterization of an endoalpha-N-acetylgalactosaminidase from the culture of medium of Diplococcus pneumoniae. J. Biochem. 80 (1976) 1–8. Search in Google Scholar
[38] Drzeniek, Z., Krotkiewski, H., Syper, D. and Lisowska, E. Reactivity of glycosidase-treated, blood-group M and N glycopeptides with lectins. Carbohydr. Res. 120 (1983) 315–321. http://dx.doi.org/10.1016/0008-6215(83)88025-210.1016/0008-6215(83)88025-2Search in Google Scholar
[39] Mishell, R.I. and Dutton, R.W. Immunization of dissociated spleen cell cultures from normal mice. J. Exp. Med. 126 (1967) 423–442. http://dx.doi.org/10.1084/jem.126.3.42310.1084/jem.126.3.423Search in Google Scholar
[40] Hansen, M.B., Nielsen, S.E. and Berg, K. Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill. J. Immunol. Methods. 119 (1989) 203–210. http://dx.doi.org/10.1016/0022-1759(89)90397-910.1016/0022-1759(89)90397-9Search in Google Scholar
[41] Vogel, H.J., Schibli, D.J., Jing, W., Lohmeier-Vogel, E.M., Epand, R.F. and Epand, R.M. Towards a structure-function analysis of bovine lactoferricin and related tryptophan- and arginine-containing peptides. Biochem. Cell Biol. 80 (2002) 49–63. http://dx.doi.org/10.1139/o01-21310.1139/o01-213Search in Google Scholar
[42] Sato, S., Tuscano, J.M., Inaoki, M. and Tedder, T.F. CD22 negatively and positively regulates signal transduction through the B lymphocyte antigen receptor. Semin. Immunol. 10 (1998) 287–297. http://dx.doi.org/10.1006/smim.1998.012110.1006/smim.1998.0121Search in Google Scholar
[43] Rosenthal, G.J., Weigand, G.W., Germolec, D.R., Blank, J.A. and Luster, M.I. Suppression of B cell function by methotrexate and trimetrexate. Evidence for inhibition of purine biosynthesis as a major mechanism of action. J. Immunol. 141 (1988) 410–416. Search in Google Scholar
[44] Genestier, L., Paillot, R., Fournel, S., Ferraro, C., Miossec, P. and Revillard, J.P. Immunosuppressive properties of methotrexate: apoptosis and clonal deletion of activated peripheral T cells. J. Clin. Invest. 102 (1998) 322–328. http://dx.doi.org/10.1172/JCI267610.1172/JCI2676Search in Google Scholar
[45] Danzer, C.P., Collins, B.E., Blixt, O., Paulson, J.C. and Nitschke, L. Transitional and marginal zone B cells have a high proportion of unmasked CD22: implications for BCR signaling. Int. Immunol. 15 (2003) 1137–1147. http://dx.doi.org/10.1093/intimm/dxg11410.1093/intimm/dxg114Search in Google Scholar
[46] Kawasaki, Y., Sato, K., Shinmoto, H. and Dosako, S. Role of basic residues of human lactoferrin in the interaction with B lymphocytes. Biosci. Biotechnol. Biochem. 64 (2000) 314–318. http://dx.doi.org/10.1271/bbb.64.31410.1271/bbb.64.314Search in Google Scholar
[47] Artym, J., Zimecki, M., Paprocka, M. and Kruzel, M.L. Orally administered lactoferrin restores humoral immune response in immunocompromised mice. Immunol. Lett. 89 (2003) 9–15. http://dx.doi.org/10.1016/S0165-2478(03)00102-010.1016/S0165-2478(03)00102-0Search in Google Scholar
[48] Actor, J.K., Hwang, S.A., Olsen, M., Zimecki, M., Hunter, R.L., Jr. and Kruzel, M.L. Lactoferrin immunomodulation of DTH response in mice. Int. Immunopharmacol. 2 (2002) 475–486. http://dx.doi.org/10.1016/S1567-5769(01)00189-810.1016/S1567-5769(01)00189-8Search in Google Scholar
[49] Boswell, H.S., Nerenberg, M.I., Scher, I. and Singer, A. Role of accessory cells in B cell activation. III. Cellular analysis of primary immune response deficits in CBA/N mice: presence of an accessory cell-B cell interaction defect. J. Exp. Med. 152 (1980) 1194–1309. http://dx.doi.org/10.1084/jem.152.5.119410.1084/jem.152.5.1194Search in Google Scholar
[50] Nakae, S., Asano, M., Horai, R. and Iwakura, Y. Interleukin-1 beta, but not interleukin-1 alpha, is required for T-cell-dependent antibody production. Immunology 104 (2001) 402–409. http://dx.doi.org/10.1046/j.1365-2567.2001.01337.x10.1046/j.1365-2567.2001.01337.xSearch in Google Scholar
[51] Zucali, J.R., Broxmeyer, H.E., Levy, D. and Morse, C. Lactoferrin decreases monocyte-induced fibroblast production of myeloid colony-stimulating activity by suppressing monocyte release of interleukin-1. Blood 74 (1989) 1531–1536. Search in Google Scholar
[52] Leutwyler, C., Schalch, L. and Jungi, T.W. Evidence for interleukin-1 beta being a necessary but not sufficient co-stimulatory signal in monocytedependent anti-CD3-mediated T-cell triggering. Immunol. Lett. 38 (1993) 33–39. http://dx.doi.org/10.1016/0165-2478(93)90115-I10.1016/0165-2478(93)90115-ISearch in Google Scholar
[53] Zimecki, M., Kocieba, M. and Kruzel, M. Immunoregulatory activities of lactoferrin in the delayed type hypersensitivity in mice are mediated by a receptor with affinity to mannose. Immunobiology 205 (2002) 120–131. http://dx.doi.org/10.1078/0171-2985-0011510.1078/0171-2985-00115Search in Google Scholar PubMed
© 2013 University of Wrocław, Poland
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.